Jane Street’s Quoin Pharmaceuticals QNRX Stock Holding History

Jane Street’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28	Closed	-$26K	–	9943
2022 Q3	$26K	Buy	+28	New	+$57.6K	﹤0.01%	9132
2016 Q4	–	Hold	0	–	-$76K	–	4506
2016 Q3	–	Hold	0	–	–	–	3874

Other funds holding QNRX

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jane Street's QNRX Position: Q4 2022 in Review

Jane Street sold out of Quoin Pharmaceuticals (QNRX) in Q4 2022, closing a stake of 28 shares — an estimated $26K sold.

Jane Street first reported a position in QNRX in Q3 2022 and held it in 1 quarter. The position peaked at $26K in Q3 2022. 3 funds tracked by Wall St. Rank hold QNRX as of Q4 2022.

Jane Street reported no remaining Quoin Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Jane Street sold 28 Quoin Pharmaceuticals shares in Q4 2022, an estimated $26K.
Jane Street first reported a position in Quoin Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Jane Street's Quoin Pharmaceuticals position peaked at $26K in Q3 2022.
3 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.